March SEC Meeting: Spotlight on Ethereum ETFs; AI Crypto Aspires to Outshine Injective

The US Securities and Exchange Commission (SEC) is preparing to discuss the potential drawbacks and benefits of spot Ethereum (ETH) exchange-traded funds with asset managers from pending applications like VanEck and Grayscale.

The SEC’s approval of exchange-traded funds that fit its ETF acceptance criteria has taken BTC prices close to historic highs with tokens trading at over $68,000. An Ethereum ETF being approved is expected to have a similar effect on Ether prices. Rumors about the new asset class being created have had a positive effect on ETH prices with 54% growth in the last 30 days.

InQubeta (QUBE), a crowdfunding investment platform launched on the Ethereum network, has also been in the news a lot lately as it emerges as one of the top ICOs thanks to the $10.9 million raised through token sales. It’s an emerging crypto that looks to provide easier access to investments in the artificial intelligence (AI) sector.

Injective (INJ) was one of the top-performing AI-focused cryptocurrencies in 2024, and its prices have grown by over 1,000% in the past 12 months. It hosts one of the largest ecosystems around for decentralized finance, offering its users services like spot exchanges and prediction models.

InQubeta (QUBE) could be the best crypto to invest in right now

InQubeta’s early investors have enjoyed 250% gains so far and they would have earned 440% returns by the time tokens are unleashed on exchanges. Its ecosystem connects AI startups with financiers, to help advance the AI revolution.

AI has emerged as one of the fastest-growing tech sectors and that has been accompanied by an influx of investment capital. AI investments have gone from $12 billion to $120 billion in the past seven years, and more than $1.5 billion is expected to enter the industry by 2030.

AI will change how the world works in the coming years and it will create once-in-a-lifetime investment opportunities that can help build generational wealth. That’s always the case with tech revolutions and it won’t be much different with AI. Investors who invested in companies like Netflix have earned substantial returns since then and a lot more money is being invested in AI compared to what went into dotcoms in the late 90s.

Here’s how InQubeta’s investment process works:

Ethereum (ETH) prices expected to skyrocket with ETF approvals

Buying up Ethereum is a good crypto investment at the moment given the strong likelihood of spot ETFs being approved soon. Prices have been enjoying steady growth for the past few weeks, as was the case with BTC prices leading up to the ETFs being launched.

The approval of Bitcoin ETFs has opened the way for other cryptocurrencies to launch exchange-traded funds.

Analysts predict Injective (INJ) prices to grow as much as 2,000% in 2024

Injective has emerged as the most robust decentralized space and it is expected to dominate the DeFi sector in the coming years as its user base expands. It provides its users with many of the services they would find on decentralized exchanges.

Summary

QUBE, INJ, and ETH are three of the best altcoins to buy today to earn exponential profits in the next several months. QUBE will likely enjoy the most growth in 2024, while INJ comes in a close second.

Visit InQubeta Presale

Join The InQubeta Communities

Disclaimer: This is a paid release. The statements, views and opinions expressed in this column are solely those of the content provider and do not necessarily represent those of Bitcoinist. Bitcoinist does not guarantee the accuracy or timeliness of information available in such content. Do your research and invest at your own risk.

Exit mobile version